Magnimus Pharmaceutical Industries Private Limited, a active private limited company, was established on 21 February 2019 in Amritsar, Punjab, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24110PB2019PTC049085. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Employing 3 professional, Its leadership includes Karan Goyal (Director), Subhash Chander (Director). Past directors included Karan Goyal, Sarvinder Singh, Subhash Chander. It holds ₹1.53 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 8Th Km Stone, G.T. Road, Vill. Rampura P.O. Jheete Kalan, Daburji, Amritsar, Punjab, 143115.
U24110PB2019PTC049085
049085
21 February 2019
₹1.00 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Magnimus Pharmaceutical Industries Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karan Goyal | Director | 24 May 2023 | Current |
| Subhash Chander | Director | 24 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Managing Director | 08 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 13 Jun 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Magnimus Pharmaceutical Industries Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 170.11% increase. The company also saw a substantial improvement in profitability, with a 42.33% increase in profit. The company's net worth Soared by an impressive increase of 40.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Magnimus Pharmaceutical Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹15,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2023 | Others | ₹5.50 M | Open |
| 29 Jul 2022 | Others | ₹9.80 M | Open |
Explore comprehensive loan charge details -
Magnimus Pharmaceutical Industries has a workforce of 3 employees as of Nov 19, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Magnimus Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnimus Pharmaceutical Industries's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Magnimus Pharmaceutical Industries Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Magnimus Pharmaceutical Industries Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
The activity Karan Goyal was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 6 months . was completed.
Progress on Subhash Chander was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 2 years 6 months . was documented.
A charge with Others amounted to Rs. 5.50 M with Charge ID 100694925 was registered on 20 Mar 2023. was recorded as a recent event.
A charge with Others amounted to Rs. 9.80 M with Charge ID 100607933 was registered on 29 Jul 2022. was recorded as a recent event.
The CIN of Magnimus Pharmaceutical Industries Private Limited is U24110PB2019PTC049085.
Magnimus Pharmaceutical Industries Private Limited is headquartered at 8Th Km Stone, G.T. Road, Vill. Rampura P.O. Jheete Kalan, Daburji, Amritsar, Punjab, 143115.
Magnimus Pharmaceutical Industries Private Limited was incorporated on 21 February 2019.
The current directors of Magnimus Pharmaceutical Industries Private Limited are
The primary industry of Magnimus Pharmaceutical Industries Private Limited is Trade.
Magnimus Pharmaceutical Industries Private Limited is unlisted.
The authorized capital of Magnimus Pharmaceutical Industries Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX